borderline significancep = 0.076
The PSA level of subjects with prostate cancer was higher (27.9 ± 57.2 ng/mL) than of subjects without prostate cancer (6.7 ± 4.1 ng/mL) with borderline significance ( p = 0.076).
The PSA level of subjects with prostate cancer was higher (27.9 ± 57.2 ng/mL) than of subjects without prostate cancer (6.7 ± 4.1 ng/mL) with borderline significance ( p = 0.076).